|
Volumn 43, Issue 1, 2001, Pages 21-25
|
Treatment of continuous renal replacement therapy in patients with burn injuries
a a a a a |
Author keywords
Continous renal replacement therapy; Renal and non renal indications; Systemic inflammatory response
|
Indexed keywords
COMPLEMENT COMPONENT C3A;
COMPLEMENT COMPONENT C5A;
CYTOKINE;
ENDOTOXIN;
INTERLEUKIN 1;
INTERLEUKIN 2;
INTERLEUKIN 6;
LEUKOTRIENE;
THROMBOCYTE ACTIVATING FACTOR;
THROMBOXANE A2;
TUMOR NECROSIS FACTOR ALPHA;
UREA;
WATER;
ADULT;
AGED;
ARTICLE;
BURN;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTINUOUS RENAL REPLACEMENT THERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRITICAL ILLNESS;
CZECH REPUBLIC;
FLUID BALANCE;
HEMODIALYSIS;
HEMOFILTRATION;
HUMAN;
INFLAMMATION;
KIDNEY FAILURE;
ADOLESCENT;
ADULT;
AGED;
BURNS;
HEMODIAFILTRATION;
HEMOFILTRATION;
HUMANS;
INFLAMMATION MEDIATORS;
KIDNEY FAILURE;
MIDDLE AGED;
MULTIPLE ORGAN FAILURE;
PATIENT SELECTION;
|
EID: 0035005064
PISSN: 00015423
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (18)
|